The largest database of trusted experimental protocols

Eclusys trab

Manufactured by Roche
Sourced in Japan

The ECLusys TRAb is a laboratory equipment product designed for the detection and quantitative measurement of thyroid-stimulating hormone receptor (TSHR) antibodies in human serum or plasma samples. The core function of this product is to provide accurate and reliable results for the assessment of thyroid autoimmune disorders.

Automatically generated - may contain errors

2 protocols using eclusys trab

1

Thyroid Function Assessment During Pregnancy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Free triiodothyronine (FT 3 ) and free thyroxine (FT 4 ) levels were measured by an electrochemiluminescence immunoassay (ECLIA) (ECLusys FT 4 , Roche Diagnostics GmbH, Mannheim, Germany; manufacturer's reference limits: 2.2-4.3 pg/mL, 0.8-1.6 ng/ dL respectively). The TSH level was measured by an ECLIA (ECLusys TSH; Roche Diagnostics GmbH, Mannheim, Germany; manufacturer's reference limits: 0.2-4.5 mIU/L). Based on the results of our previous study of a large population, the reference intervals for FT 3, and FT 4, and TSH at 4-12 weeks of gestation were 2.01-4.9 pg/mL, 0.77-1.91 ng/dL, and 0.01-3.35 mIU/L, respectively.
TPOAb and TgAb were determined by an ECLIA performed with Roche ECLusys Anti-Tg and Anti-TPO (Roche Diagnostics GmbH, Mannheim, Germany; reference values were: TPOAb, ≤28 IU/mL; TgAb, ≤40 IU/mL). Until September 30, 2008, TRAb levels were determined with a solid-phase immunoradioreceptor assay kit (RSR, Cardiff, UK; TRAb-CT; reference values <10%), but since October 1, 2008, they have been determined with an electrochemiluminescence immunoassay kit (ECLusys TRAb; Roche Diagnostics GmbH, Mannheim, Germany; reference values <2.0
+ Open protocol
+ Expand
2

Thyroid Function and Autoantibody Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected from all patients. FT4, FT3, and TSH values were measured using a commercial electrochemiluminescence immunoassay (Roche Diagnostics, Tokyo; FT4: normal range, 1.00-1.70 ng/ dL; FT3: normal range, 2.40-4.50 pg/mL; TSH: normal range, 0.56-4.30 μIU/mL). Serum TRAb was measured using a two-step radioreceptor assay DYNO test TRAb (Yamasa Corp, Tokyo; normal range, <1.0 IU/L; detectable level, ≥ 1.0 IU/L) between January 1, 2009 and May 12, 2011 for 61 patients, and another two-step radioreceptor assay ECLusys TRAb (Roche Diagnostics, Tokyo; normal range, <2.0 IU/L; detectable level, ≥ 0.3 IU/L) between May 14, 2011 and December 31, 2013 for 33 patients. TRAb levels measured using ECLusys TRAb were converted to DYNO test TRAb equivalents using the following formula: ECLusys TRAb (IU/L) = 1.08 × [DYNO test TRAb (IU/L)] -0.55 (Supplemental Fig. 1). This formula was based on Schott's formula [3] . Most patients with painless thyroiditis had undetectable levels of TRAb. These TRAb values were set at 1.0 IU/L for analysis. Thyroid autoantibodies [thyroglobulin antibody (TgAb) and thyroid peroxidase antibody (TPOAb)] were measured using a radioimmunoassay (Cosmic Corp, Tokyo).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!